<DOC>
	<DOCNO>NCT02624505</DOCNO>
	<brief_summary>The purpose study demonstrate pharmacodynamic bioequivalence test product reference product , use bronchoprovocation ( methacholine challenge test ) adult patient stable mild asthma .</brief_summary>
	<brief_title>Pharmacodynamic Bioequivalence Metered Dose Inhalers Albuterol Sulfate Patients With Stable Mild Asthma</brief_title>
	<detailed_description>This study demonstrate pharmacodynamic bioequivalence test product reference product term FEV1 measure different time-points , use bronchoprovocation ( methacholine challenge test ) adult patient stable mild asthma .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Albuterol</mesh_term>
	<criteria>Male nonpregnant female subject ( 1865 year age ) Forced Expiratory Volume 1 second ( FEV1 ) ≥ 80 % predict . Airway responsiveness methacholine demonstrate prealbuterol dose ( baseline ) PC20 ≤ 8 mg/ml . Stable mild asthmatic base National Asthma Education Prevention Program ( NAEPP ) guideline . Nonsmokers least 6 month prior study maximum smoke history five packyears ( equivalent one pack per day five year ) . Written informed consent . Conditions could alter airway reactivity methacholine ( e.g. , pneumonia , upper respiratory tract infection , viral bronchitis and/or sinobronchitis ) within six week prior screen visit . History seasonal asthma exacerbation , case patient study outside relevant allergen season . History clinically significant disease abnormality include congestive heart failure , uncontrolled hypertension , uncontrolled coronary artery disease , myocardial infarction , cardiac dysrhythmia . History cystic fibrosis , bronchiectasis respiratory disease Asthma Historical current evidence significant hematologic , hepatic , neurologic , psychiatric , renal , diseases Known intolerance hypersensitivity hypersensitivity component albuterol meter dose inhaler ( MDI ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>